Stockreport

EyePoint Pharmaceuticals Inc (EYPT) Reports Growth Amidst Strategic Shifts in Q4 and Full-Year 2023 [Yahoo! Finance]

EyePoint Pharmaceuticals, Inc.  (EYPT) 
Last eyepoint pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
PDF Royalties and Collaborations Revenue: Rose significantly to $13.3 million in Q4 2023. Operating Expenses: Decreased to $30.4 million in Q4 2023 from $54.3 million in [Read more]